Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 9/20 | 0.41 |
| ▸ | NPY1R | P25929 | 5/20 | 0.41 |
| ▸ | NPY2R | P49146 | 4/20 | 0.41 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.41 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.37 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.36 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29391114 | 0.94 | NOD1 (0.44) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL34464591 | 0.92 | QRFPR (0.42) | NPY4RNPY1RNPY2RNPY5RQRFPR | |
| SCHEMBL30567417 | 0.92 | NOD1 (0.42) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL30193233 | 0.92 | NMT1 (0.44) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL30786580 | 0.92 | NPY4R (0.49) | NPY4RNPY1RNPY2RNPY5ROPRM1 | |
| SCHEMBL29591553 | 0.91 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL27086399 | 0.90 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL27086388 | 0.90 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL6237668 | 0.90 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL13655536 | 0.90 | NMT1 (0.43) | NPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |